company_name = Abbott Laboratories
company_type = Public (nyse|ABT)
company_slogan = A promise for life
location = Abbott Park,
North Chicago, Illinois, USA
Miles D. White, Chairman and CEO
revenue = increase $25.914 billion USD (
net_income = increase $3.606 billion USD (
num_employees = 68,000
products = Pharmaceutical products, medical devices, diagnostic assays,nutritional products and animal health products
homepage = [http://www.abbott.com/ www.abbott.com/]
Abbott Laboratories (nyse|ABT) is a diversified pharmaceuticals
health carecompany. It has 68,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois.
Abbott Laboratories was founded by Chicago
physician Wallace Calvin Abbottin 1888. In 2007, Abbott had over $25 billion in revenue.
1985, the company developed the first HIVblood screening test. The company's drug portfolio includes " Humira", a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasisand juvenile idiopathic arthritis; " Norvir", a treatment for HIV; " Depakote", an anticonvulsantdrug; and " Synthroid", a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassayproducts as well as nutritional products, including " Ensure", a line of well known meal replacement shakes.Abbott’s in vitro diagnostics business is a world leader in immunoassays and blood screening. Abbott’s broad range of medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other important indicators of general health. Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals critical diagnostics information accurately and immediately at the point of patient care. In addition to its offerings in the blood gas and chemistries segment, Abbott also provides point-of-care cardiac assays to the emergency room.
Abbott's core businesses focus on pharmaceuticals, medical devices and nutritional products, which have been supplemented through several notable acquisitions. It has also divested itself of less profitable businesses through sales and spinoffs.
In 2001, Abbott acquired Knoll, the pharmaceutical division of
In 2004, Abbott spun off its hospital products division into a new 14,000 employee company named
Hospira, and acquired TheraSense, a diabetescare company, which it merged with its MediSense division to become Abbott Diabetes Care. In 2006, Abbott assisted Boston Scientificin its purchase of GuidantCorporation. As part of the agreement, Abbott purchased the vascular device division of Guidant.
In January 2007, Abbott Laboratories agreed to sell its in vitro diagnostics and Point-of-Care diagnostics divisions to
General Electricfor more than $8 billion. These units were slated to be integrated into the GE Healthcarebusiness unit. The transaction was approved by the Boards of Directors of Abbott and GE and was targeted to close in the first half of 2007. However, on July 11th, 2007, Abbott announced that it had terminated its agreement with GE because both parties could not agree on terms of the deal. [ [http://www.bloomberg.com/apps/news?pid=20601087&refer=home&sid=aLKvFFqD3DQw Bloomberg.com: Worldwide ] ]
On September 8th, 2007, Abbott completed the sale of the UK manufacturing plant at
Queenboroughto Aesica Pharmaceuticals, a Private equity-owned UK manufacturer. No announcements have been made restricting the movement of staff to Abbott unlike other sell outs.
In 1888 at the age of 30, Dr. Wallace C. Abbott founded the Abbott Alkaloidal Company. At the time he was a practicing physician and owned a drug store. His innovation was the use of the active - or alkaloid - part of a medicinal plant that he formed into tiny pills which he called “dosimetric granules.” This was successful since it allowed more consisitent and effective dosages for patients.
Some of the key products produced by Abbott Laboratories, circa 2006, include:
* Biaxin/Klacid (
* Depacon (
* Depakote (
* Gengraf (
* Gopten/Mavik (
* Humira (
* Isoptin (
* Hytrin (
* Kaletra (
* Meridia/Reductil (
* Norvir (
* Omnicef (
* Synthroid (
* Tarka (
* Tricor (
* Ultane (
* Niaspan (
* Azmacort (
* Simcor (
* Advicor (
* Simdax (
levosimendan) - not approved in US
* Similac-LF (Infant milk powder Lactose free)
* Pedia Sure
* Gain (infant formula milk)
* FreeStyle Freedom Blood Glucose Monitor
* FreeStyle Flash Blood Glucose Monitor
* FreeStyle Lite Blood Glucose Monitor
* FreeStyle Navigator Continuous Blood Glucose Monitor
* Abbott Aeroset
* Abbott CELL-DYN (
Complete blood countanalyzer)
Abbott manufactures fully automated random access
automated analyzers utilized by medical technologists in medical laboratories. Abbott also provides client support for these instruments.
A plaintiffs group in Washington, D.C., has filed a $5.2 billion lawsuit against Purdue Pharma LP and Abbott Laboratories Inc., charging the drug companies with allegedly failing to warn patients that the painkiller OxyContin is dangerously addictive. [http://www.noeman.org/drugs/drug_addiction_facts.html] Abbott no longer markets OxyContin.
Prevacid also generated a lawsuit filed by New Orleans physician John LaCorte claiming that TAP violated its agreement to offer Medicaid its "best price" for Prevacid by charging the agency up to 20 times more for the drug than it charged some of its other customers. LaCorte sued TAP on behalf of the federal government and is seeking triple damages, plus a $10,000 fine for each violation. He alleges fraudulent behavior that, he says, dates back more than a decade. [http://www.thestreet.com/stocks/melissadavid/10184941.html]
Bristol-Myers SquibbCo. is suing Abbott Laboratories claiming that SimilacSimplePac packages use a "container and scoop arrangement", which is an infringement of the 2006 patentissued to Bristol-Myers. Bristol-Myers is seeking compensation and is requesting that Abbott discontinue the sale of the containers specified. Abbott says that the SimplePac design was independently researched and produced. [cite web | url=http://www.chicagotribune.com/business/chi-thu-brf3-abbott-suit-sep18,0,2908036.story | title="Abbott sued over Similac packaging" | publisher=Chicago Tribune | date=2008-09-18 | accessdate=2008-09-18]
Pricing of Norvir
Abbott caused controversy in 2003 over a sharp rise in price of Norvir treatment from $1.71 per day to $8.57 per day, spurring claims of
price gougingby consumer groups and some members of Congress. Critics point out that Abbott received $3.5 million in grants from the United Statestaxpayers to develop Norvir, although the company has responded by pointing out the nearly $200 million development cost for the drug.
Consumer rights group
Essential Inventionspetitioned the National Institutes of Healthto override Abbott's patent on Norvir, but the agency refused to do so on August 4, 2004, citing potential widespread adverse effects on the pharmaceuticalmarket.
Florida fraud action
In, 2006, there is an unpopular example of Abbott Laboratories fraud action which is now under the USA FLORIDA State's Jury trial processing. This fraud action is about the "USA STATE of FLORIDA Medicare and Medicaid programs" where Abbott reported inflated pharmaceutical prices - often 1000% higher than Abbott's actual prices. [http://www.usdoj.gov/usao/fls/PressReleases/Attachments/060518-01.ABBOTT_Complaint.pdf]
Access to Kaletra
In 2006, Abbott began working with many countries to register the new version of Kaletra in response to protesters from many organizations, including
Doctors Without Borders, the Student Global AIDS Campaign, and Act Up. The protests were held at Abbott's offices and laboratories across the US (including in Illinois, Virginia, New Jersey, and Florida), demanding that Abbott actively take part in registering Kaletra in developing countries, to create "affordable" prices in middle-income countries, to establish a pediatric version of the drug (in addition to the liquid that is currently available), and to create open licenses to allow for generic drugs to be made before expiration of the patents.
In March 2007, Abbott announced it will not be introducing any new medicines into Thailand, because Thailand had decided to disregard international intellectual property rights and manufacture its own generic version of Kaletra. Thailand, a country with a per capita income of about $2,742, had recently issued WTO-compliant compulsory licenses to allow government use of this drug and efavirenz for treatment of the estimated 600,000 people living with HIV/AIDS in that country. [http://news.bbc.co.uk/1/hi/world/asia-pacific/6310515.stm Accessed 05 March 2008] Fact|date=March 2007
* [http://freestylenavigator.com/ FreeStyle Navigator Continuous Blood Glucose Monitor]
* [http://www.abbott.com/global/url/home/en_US Abbott Labs Global Health Care & Medical Research]
* [http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0420.htm/ Abbott/GE deal for core lab diagnostics business]
* [http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0494.htm/ Abbott terminates deal with GE]
* [http://www.abbott.gr/ Abbott Hellas]
* [http://www.pharmaceutical-business-review.com/companyprofile.asp?guid=43227671-2079-49CF-A188-287DAE6EB406 Abbott Labs company profile and news archive]
* [http://www.washingtonpost.com/wp-dyn/articles/A40430-2004Aug4.html NIH Won't Intervene in AIDS Drug Pricing Issue] ,
The Washington Post, August 4, 2004
*Abbott Laboratories timeline [http://www.abbott.com/global/url/content/en_US/10.30:30/general_content/General_Content_00069.htm]
*CELL-DYN Hematology Analyzer [http://www.abbottdiagnostics.com/Products/Instruments_by_Platform/yl.cfm?syscat=Hematology]
Wikimedia Foundation. 2010.
Look at other dictionaries:
Abbott Laboratories — Rechtsform Aktiengesellschaft ISIN US0028241000 … Deutsch Wikipedia
Abbott Laboratories — Ти … Википедия
Abbott Laboratories — Laboratoires Abbott Logo de Laboratoires Abbott Création 1888 Forme juridique s … Wikipédia en Français
Abbott Laboratories v. Gardner — Infobox SCOTUS case Litigants=Abbott Laboratories v. Gardner ArgueDate=January 16 ArgueYear=1967 DecideDate=May 22 DecideYear=1967 FullName=Abbott Laboratories et al. v. Gardner, Secretary of Health, Education, and Welfare, et al. USVol=387… … Wikipedia
Sindell v. Abbott Laboratories — Sindell v. Abbott Laboratories, [http://online.ceb.com/calcases/C3/26C3d588.htm 26 Cal. 3d 588] (1980), was a landmark products liability decision of the Supreme Court of California which pioneered the doctrine of market share liability.… … Wikipedia
Abbott — may refer to:Places in the United States* Abbott, Arkansas * Abbott, California * Abbott, Iowa * Abbott, Mississippi * Abbott, Nebraska * Abbott, New Mexico * Abbott, Texas * Abbott, Virginia * Abbott, West Virginia * Abbott Township,… … Wikipedia
Abbott — steht für: Abbott (Familienname) Abbott Laboratories, ein US amerikanisches Pharmaunternehmen (17023) Abbott, ein Asteroid des Hauptgürtels Abbott ist der Name folgender Orte: Abbott (Buenos Aires), Ort in der Provinz Buenos Aires, Argentinien… … Deutsch Wikipedia
Abbott Axsym — The Abbott Axsym is an immunochemical automated analyser made by Abbott Laboratories. It is used for serology tests and therapeutic drug monitoring, and uses antibodies to alter the deflection of polarised light. It can also be used to monitor… … Wikipedia
abbott — nembutal sleeping tablet (nicknamed for its producer, Abbott Laboratories) … Eponyms, nicknames, and geographical games
Deutsche Abbott GmbH — Abbott Laboratories Unternehmensform Aktiengesellschaft Gründung 1888 … Deutsch Wikipedia